tiprankstipranks
Checkpoint Therapeutics confirms FDA approval of unloxcyt
PremiumThe FlyCheckpoint Therapeutics confirms FDA approval of unloxcyt
9d ago
Checkpoint Therapeutics’ unloxcyt approved by FDA
Premium
The Fly
Checkpoint Therapeutics’ unloxcyt approved by FDA
9d ago
Checkpoint Therapeutics trading halted, news pending
Premium
The Fly
Checkpoint Therapeutics trading halted, news pending
9d ago
Checkpoint Therapeutics price target lowered to $20 from $34 at H.C. Wainwright
PremiumThe FlyCheckpoint Therapeutics price target lowered to $20 from $34 at H.C. Wainwright
4M ago
Checkpoint Therapeutics reports Q2 EPS (18c) vs ($1.05) last year
Premium
The Fly
Checkpoint Therapeutics reports Q2 EPS (18c) vs ($1.05) last year
4M ago
Checkpoint announces FDA acceptance of BLA resubmission for cosibelimab
Premium
The Fly
Checkpoint announces FDA acceptance of BLA resubmission for cosibelimab
5M ago
Checkpoint Therapeutics resubmits BLA for cosibelimab in carcinoma
PremiumThe FlyCheckpoint Therapeutics resubmits BLA for cosibelimab in carcinoma
6M ago
Checkpoint announces FDA alignment enabling cosibelimab BLA resubmission
Premium
The Fly
Checkpoint announces FDA alignment enabling cosibelimab BLA resubmission
6M ago
Checkpoint Therapeutics: Key Governance and Growth Decisions Approved
Premium
Company Announcements
Checkpoint Therapeutics: Key Governance and Growth Decisions Approved
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100